Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark.
Pancreatology. 2011;11(4):376-82. doi: 10.1159/000330224. Epub 2011 Aug 30.
Patients with chronic pancreatitis (CP) often develop fat malabsorption and are susceptible to hypovitaminosis D.
We wanted to evaluate the intestinal uptake of cholecalciferol in patients with CP and fat malabsorption.
We did a prospective placebo-controlled study including patients with verified CP and fat malabsorption. They were randomized to 10 weeks of (A) ultraviolet radiation B (UVB) 6 min weekly in a commercial tanning bed, (B) vitamin D supplement 1,520 IU/daily, or (C) placebo. The vitamin D metabolites 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (calcitriol) were quantified at the start and end of the study.
In total 30 patients were randomized and 27 completed the study. Compliance to tablets and tanning sessions was >80%. The changes in 25OHD levels in group B (32.3 nmol/l; 95% CI 15-50) were significantly greater than changes in group A (p < 0.001) and group C (p < 0.001). Changes in group A (1.1 nmol/l) did not differ from the placebo group (p = 0.9). Changes in calcitriol levels were identical between groups.
Daily vitamin D supplements increased 25OHD in patients with CP compared to placebo whereas weekly tanning bed sessions did not.
慢性胰腺炎(CP)患者常发生脂肪吸收不良,且易患维生素 D 缺乏症。
我们旨在评估脂肪吸收不良的 CP 患者体内胆钙化醇的肠道摄取情况。
我们进行了一项前瞻性安慰剂对照研究,纳入了确诊 CP 伴脂肪吸收不良的患者。他们被随机分配至以下三组,接受为期 10 周的治疗:(A)每周在商业日光浴床中接受 6 分钟紫外线 B(UVB)照射;(B)每日补充维生素 D 1520IU;或(C)安慰剂。在研究开始和结束时,对维生素 D 代谢物 25-羟维生素 D(25OHD)和 1,25-二羟维生素 D(骨化三醇)进行定量检测。
共有 30 名患者被随机分配,其中 27 名完成了研究。片剂和日光浴治疗的依从性均>80%。B 组(32.3nmol/L;95%CI 15-50)25OHD 水平的变化明显大于 A 组(p<0.001)和 C 组(p<0.001)。A 组(1.1nmol/L)的变化与安慰剂组无差异(p=0.9)。各组间骨化三醇水平的变化无差异。
与安慰剂相比,每日维生素 D 补充剂可增加 CP 患者的 25OHD,而每周日光浴床治疗则没有这种效果。